Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics

There is currently an urgent need for biomarkers that can be used to monitor the efficacy of experimental therapies for Duchenne Muscular Dystrophy (DMD) in clinical trials. Identification of novel protein biomarkers has been limited due to the massive complexity of the serum proteome and the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Coenen-Stass, Anna M. L., McClorey, Graham, Manzano, Raquel, Betts, Corinne A., Blain, Alison, Saleh, Amer F., Gait, Michael J., Lochmüller, Hanns, Wood, Matthew J. A., Roberts, Thomas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655324/
https://www.ncbi.nlm.nih.gov/pubmed/26594036
http://dx.doi.org/10.1038/srep17014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655324/
https://www.ncbi.nlm.nih.gov/pubmed/26594036
http://dx.doi.org/10.1038/srep17014

Ejemplares similares